Detalles de la búsqueda
1.
Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays.
Mol Pharm
; 20(11): 5690-5700, 2023 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37773975
2.
Elucidating Molecular- and Particle-Level Changes during the Annealing of a Micronized Crystalline Drug.
Mol Pharm
; 16(10): 4339-4351, 2019 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31454254
3.
The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate.
AAPS PharmSciTech
; 16(3): 589-600, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25398478
4.
An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations.
AAPS PharmSciTech
; 15(4): 898-909, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24756910
5.
Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks.
AAPS PharmSciTech
; 15(4): 1009-20, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24831088
6.
Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations.
Pharm Res
; 29(4): 994-1006, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22161310
7.
A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products.
AAPS J
; 23(4): 73, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34008082
8.
Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?
AAPS J
; 23(3): 48, 2021 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33768368
9.
Simulation Informed Design and Performance of In Vitro Bioequivalence Trials for Particle Size Distributions.
AAPS J
; 22(6): 139, 2020 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33104941
10.
Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug Products.
AAPS J
; 22(2): 47, 2020 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32060670
11.
Engineering of crystalline combination inhalation particles of a long-acting beta2-agonist and a corticosteroid.
Pharm Res
; 26(12): 2657-66, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19784762
12.
An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.
Eur J Pharm Biopharm
; 69(2): 496-507, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18191553
13.
The use of atomic force microscopy to study the conditioning of micronised budesonide.
Int J Pharm
; 357(1-2): 314-7, 2008 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-18342461
14.
Factors affecting defining the quality and functionality of excipients used in the manufacture of dry powder inhaler products.
Drug Dev Ind Pharm
; 34(9): 966-73, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18800257
15.
The spray drying of unfractionated heparin: optimization of the operating parameters.
Drug Dev Ind Pharm
; 34(6): 559-68, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18568905
16.
The influence of crystal habit on the prediction of dry powder inhalation formulation performance using the cohesive-adhesive force balance approach.
Drug Dev Ind Pharm
; 34(9): 974-83, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18622874
17.
Investigation of the enhanced antimicrobial activity of combination dry powder inhaler formulations of lactoferrin.
Int J Pharm
; 514(2): 399-406, 2016 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27628783
18.
From single excipients to dual excipient platforms in dry powder inhaler products.
Int J Pharm
; 514(2): 374-383, 2016 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27262269
19.
Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?
AAPS J
; 24(1): 1, 2021 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811595
20.
Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers.
AAPS J
; 17(5): 1105-16, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25956383